Firmoscan
Active06617668Private limited companyOxted

IMMUNOPHARMA CONSULTING LTD

Significant control: James Scott Crowe (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Immunopharma Consulting Ltd: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Immunopharma Consulting Ltd sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

IMMUNOPHARMA CONSULTING LTD is an active private limited company (company number 06617668) incorporated on 11 June 2008, registered in Oxted. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (total exemption full) but not yet parsed into this record.

There are 54 companies in research and experimental development on biotechnology in Surrey with filed accounts; the median reports net assets of £1,000 and is 11 years old.

02

Ownership and control

1 active · 2 other
  • Mr James Scott Crowe
    Individual · since 29 November 2024
    • owns 75–100% of shares
  • Mrs Anne Elizabeth Crowe
    Individual · since 12 June 2016 · ceased 29 November 2024
    • owns 75–100% of shares
  • Mr James Scott Crowe
    Individual · since 12 June 2016 · ceased 31 March 2023
    • owns 25–50% of shares

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
11 June 200818 yrs ago
First accounts due
11 March 20106071 days overdue
Confirmation statement due
25 June 2027in 244 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72110
Research and experimental development on biotechnology
Accounts type
Total Exemption Full
05

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

06

Filing and accounts signals

Facts from the register · no rating
  • Incorporated five or more years agoIncorporated 11 June 2008
  • Accounts past their due dateDue 11 March 2010

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 244 days
  2. First accounts due6071 days overdue
  3. Incorporated
08

Similar companies in Surrey

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 11 June 2008 · in Jun 2008.

09

Reminders for IMMUNOPHARMA CONSULTING LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.

This information comes from public filings and our automated processing of them. It may contain errors, be incomplete or be out of date, and is not advice or a credit reference. Check the official record before relying on it. Terms · Privacy · Report an error (corrected within one working day).